Assessment of genetic changes in hepatocellular carcinoma by comparative genomic hybridization analysis: Relationship to disease stage, tumor size, and cirrhosis

American Journal of Pathology

Volumn 154, Issue 1, 1999, Pages 37-43

  Wong, Nathalie ^a   Lai, Paul ^a   Lee, Siu Wah ^a   Fan, Susanna ^a   Pang, Elizabeth ^a   Liew, Choong Tsek ^a   Sheng, Zhong ^a   Lau, Joseph Wan Yee ^a   Johnson, Philip James ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0032919172     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65248-0     Document Type: Article

References (61)

1. World Health Organization: Cancer Research for Cancer Control. International Agency for Cancer Research, Lyon (IARC Scientific Publication), 1997, p 5
2. Doll R, Muir C, Waterhouse J: Cancer Incidence in Five Continents, vol 2. Berlin, Springer, 1970
3. Waterhouse JAH, Muir CS, CoRrea P, Powell J: Cancer Incidence in Five Continents, vol 4. International Agency for Research on Cancer, Lyon (IARC Scientific Publications 42), 1982
4. Beasley RP: Hepatitis B virus: the major etiology of hepatocellular carcinoma. Cancer 1988, 61:1942-1946
5. Munoz N, Bosch X: Epidemiology of hepatocellular carcinoma. Neoplasms of the Liver. Edited by Okuda K, Ishak KG. London, Springer Verlag, 1987
6. Johnson PJ, Williams R: Cirrhosis and the aetiology of hepatocellular carcinoma. J Hepatol 1987, 4:140-147
7. Hasan F, Jeffers LJ, De Medina M, Reddy KR, Parker T, Schiff ER, Houghton M, Choo QL, Kuo G: Hepatitis C-associated hepatocellular carcinoma. Hepatology 1990, 12:589-591
8. Lim R, Bongard FS: Hepatocellular carcinoma: changing concepts in diagnosis and management. Arch Surg 1984, 119:637
9. Lin T-Y, Lee CS, Chen KM, Chen CC: Role of surgery in the treatment of primary carcinoma of the liver: a 31 year experience. Br J Surg 1987, 74:839-842
10. Fortner JG, MacLean BJ, Kim DK, Howland WS, Turnbull AD, Goldiner P, Carlon G, Beattie EJ Jr: The seventies evolution in liver surgery for cancer. Cancer 1981, 47:2162-2166
11. Okuda K, Obata H, Nakajima Y, Ohtsuki T, Okazaki N, Ohnishi K: Prognosis of primary hepatocellular carcinoma. Hepatology 1984, 4:3-6
12. Sasaki Y, Imaoka S, Masutani S, Osashi I, Ishikawa O, Koyama H, Iwanaga T: Influence of coexisting cirrhosis on longer-term prognosis after surgery in patients with hepatocellular carcinoma. Surgery 1992, 112:515-521
13. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A, Govindarajah S: Loss of heterozygosity suggests tumour suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 1989, 86:8852-8856
14. Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A: Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene 1997, 14:2927-2933
15. Fujimori M, Tokino T, Hino O, Kitagawa T, Imamura T, Okamoto E, Mitsunobu M, Ishikawa T, Nakagama H, Harada H, Yagura M, Matsubara K, Nakamura Y: Allelotype study of primary hepatocellular carcinoma. Cancer Res 1991, 51:89-93
16. Fujimoto Y, Hampton LL, Wirth PJ, Wang NJ, Xie JP, Thorgeirsson SS: Alterations of tumor suppressor genes and allelic losses in human hepatocellular carcinomas in China. Cancer Res 1994, 54:281-285
17. Kuroki T, Fujiwara Y, Tsuchiya E, Nakamori S, Imaoka S, Kanematsu T, Nakamura Y: Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity on chromosome arm 1p occurs at an early stage of hepatocarcinogenesis. Genes Chromosomes & Cancer 1995, 13:163-167
18. Boige V, Laurent-Puig P, Fouchet P, Flejou JF, Monges G, Bedossa P, Bioulas S, Capron F, Schmitz A, Olschwang S, Thomas G: Concerted nonsyntenic allellic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res 1997, 57: 1986-1990
19. Fuijiwara Y, Monden M, Mori T, Nakamura Y, Emi M: Frequent multiplication of the long arm of chromosome 8 in hepatocellular carcinoma. Cancer Res 1993, 53:857-860
20. Bardi G, Johansson B, Pandis N, Heim S, Mandahl N, Andren-Sandberg A, Hagerstrand I, Mitelman F: Cytogenetic findings in three primary hepatocellular carcinomas. Cancer Genet Cytogenet 1992, 58:191-195
21. Chen HL, Chen YC, Chen DS: Chromosome 1p aberrations are frequent in human primary hepatocellular carcinoma. Cancer Genet Cytogenet 1996, 86:102-106
22. Simon D, Munoz SJ, Maddrey WC, Knowles BB: Chromosomal rearrangements in a primary hepatocellular carcinoma. Cancer Genet Cytogenet 1990, 45:225-260
23. Werner M, Nolte M, Gergii M, Klempnauer J: Chromosome 1 abnormalities in hepatocellular carcinoma. Cancer Genet Cytogenet 1993, 66:130
24. Kallioniemi A, Kallioniemi O-P, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D: Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992, 258:818-821
25. Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A: Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes Chromosomes & Cancer 1997, 18:59-65
26. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ (editors): Handbook for Staging of Cancer. Philadelphia, JB Lippincott, 1993
27. Antony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH: The morphology of cirrhosis: recommendations on definitions, nomenclature and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978, 31:395-414
28. Chan WY, Wong N, Chan ABW, Chow JHS, Lee JCK: Consistent copy number gain in chromosome 12 in primary diffuse large cell lymphomas of the stomach. Am J Pathol 1998, 152:11-16
29. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D: Optimizing comparative genomic hybridization for the analysis of DNA sequence copy number changes in solid tumours. Genes Chromosomes & Cancer 1994, 10:231-243
30. Qian G-S, Ross RK, Yu MC, Yuan J-M, Gao Y-T, Henderson BE, Wogan GN, Groopman JD: A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People's Republic of China. Cancer Epidemiol Biomarkers Prevention 1994, 3:3-10
31. Forus A, Weghuis DO, Smeets D, Fodstad Ø, Myklebost O, van Kessel AG: Comparative genomic hybridization analysis of human sarcomas. I. Occurrence of genomic imbalances and identification of a novel major amplicon at 1q21-q22 in soft tissue sarcomas. Genes Chromosomes & Cancer 1995, 14:8-14
32. Tarkkanen M, Karhu R, Kallioniemi A, Elomaa I, Kivioja AH, Nevalainen B, Karaharju E, Hyytinen E, Knuutila S, Kallioniemi OP: Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization Cancer Res 1995, 55:1334-1338
33. Armengol G, Tarkkanen M, Virclainen M, Forus A, Valle J, Bohling T, Asko-Sel javaara S, Blomqvist C, Elomaa I, Karaharju E, Kivioja AH, Siimes MA, Tukiainen E, Caballin MR, Myklebost O, Knuutila S: Recurrent gains of 1q. 8 and 12 in Ewing family of tumors by comparative genomic hybridization. Br J Cancer 1997, 75:1403-1409
34. Forus A, Weterman MAJ, Van Kessel AG, Berner JM, Fodstad Ø, Myklebost O: Characterisation of 1q21-22 amplifications in human sarcomas by CGH and molecular analysis. Cytogenet Cell Genet 1996, 72:148
35. Engelkamo D, Schafer BW, Mattei MG, Erne P, Heizmann CW: Six S100 genes are clustered on human chromosome 1q21: identification of two genes coding for previously unreported calcium-binding proteins S100D and S100E. Proc Natl Acad Sci USA 1993, 90:6547-6551
36. Okuda K: Hepatocellular carcinoma: recent progress. Hepatology 1992, 15:948-963
37. Santoni-Rugiu E, Nagy P, Jensen MR, Factor VM. Thorgeirsson SS: Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-α. Am J Pathol 1996, 149:407-428
38. Santoni-Rugiu E, Jensen MR, Thorgeirsson SS: Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res 1998, 58:123-134
39. Tirkkonen M, Tanner M, Karhu R, Kallioniemi A, Isola J, Kallioniemi OP: Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes & Cancer 1998, 21:177-184
40. Mahlamaki EH, Hoglund M, Gorunova L, Karhu R, Dawiskiba S, Andren-Sandberg A, Kallioniemi OP, Johansson B: Comparative genomic hybridization reveals frequent gains of 20q, 8q, 11q, 12p, and 17q, and losses of 18q, 9p, and 15q in pancreatic cancer. Genes Chromosomes & Cancer 1997, 20:383-391
41. Bockmuhl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M, Peterser I: Genomic alterations associated with malignancy in head and neck cancer. Head Neck 1998, 20:145-151
42. Bjorkqvist AM, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K, Knuutila S: Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer 1998, 77:260-269
43. Kallioniemi A, Kallioniemi OP, Citro G, Sauter G, DeVries S, Kerschmann R, Caroll P, Waldman F: Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization Genes Chromosomes & Cancer 1995, 12: 213-219
44. Visakorpi T, Kallioniemi AH, Syvanen AC, Hyytinen ER, Karhu R, Tammela T, Isola JJ, Kallioniemi OP: Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 1995, 55:342-347
45. Nakanuma Y, Terada T, Terasaki S, Ueda K, Nonomura A, Kawahara E, Matsui O: Atypical adenomatous hyperplasia in liver cirrhosis: low-grade hepatocellular carcinoma or borderline lesion? Histopathology 1990, 17:27-35
46. Lancioni R, Caramella D, Bartolozzi C, Di Coscio G: Long term follow-up study of adenomatous hyperplasia in liver cirrhosis. Ital J Gastroenterol 1994, 26:163-168
47. Schlegel J, Stumm G, Scherthan H, Bocker T, Zirngibl H, Ruschoff J, Hofstadter F: Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 1995, 55:6002-6005
48. Reznikoff CA, Belair CD, Yeager TR, Savelieva E, Bleiloch RH, Puthenveettil JA, Cuthill S: A molecular genetic model of human bladder cancer pathogenesis. Semin Oncol 1996, 23:571-584
49. Yeager TR, De Vries S, Jarrard DF, Kao C, Nakada SY, Moon TD, Bruskewitz R, Stadler WM, Meisner LF, Gilchrist KW, Newton MA, Waldman FM, Reznikoff CA: Overcoming cellular senescence in human cancer pathogenesis. Genes Dev 1998, 12:163-174
50. Savelieva E, Belair CD, Newton MA, De Vries S, Gray JW, Waldman F, Reznikoff CA: 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papilloma-virus 16 E7 transformed human uroepithelial cells. Oncogene 1997, 14:551-560
51. International Union Against Cancer: TNM classification of malignant tumor, ed. 4. Edited by Hermanek P, Sobin LH, Berlin, Springer-Verlag, 1987, pp 53-55
52. Yamamoto M, Sugahara K: Overview of the general rules for the clinical and pathological study of primary liver cancer in Japan. Primary Liver Cancer in Japan. Edited by Tobe T. Tokyo, Springer, 1992, pp 385-401
53. Llovet JM, Jordi B, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, Franca A, Bru C, Navasa M, Ayuso MDC, Sole M, Real MI, Vilana R, Rimola A, Visa J, Rodes J: Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology 1998, 27:1572-1577
54. Sasaki Y, Imaoka S, Ishiguro S, Nakano H, Kasugai H, Fujita M, Inoue E, Ishikawa O, Furukawa H, Nakamori S, Kuroda C, Iwanaga T: Clinical features of small hepatocellular carcinomas as assessed by histologic grades. Surgery 1996, 119:252-260
55. Kenmochi K, Sugihara S, Kojiro M: Relationship of histologic grade of hepatocellular carcinoma (HCC) to tumor size, and demonstration of tumor cells of multiple different grades in single small HCC. Liver 1987, 7:18-26
56. Ohnishi K, Yoshioka H, Ito S, Fujiwara K: Prospective randomized controlled trial comparing percutaneous acetic acid injection and percutaneous ethanol injection for small hepatocellular carcinoma. Hepatology 1998, 27:67-72
57. Tanaka K, Nakamura S, Numata K, Kondo M, Morita K, Kitamura T, Saito S, Kiba T, Okazaki H, Sekihara H: The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis. Cancer 1998, 82:78-85
58. Hiroshige K, Yokosuka O, Imazeki F, Saisho H, Omata M: Telomerase activity and telomere length in hepatocellular carcinoma and chronic liver disease. Gastroenterology 1997, 112:493-500
59. Urano Y, Watanabe K, Lin CC, Hino O, Tamaoki T: Interstitial chromosomal deletion within 4q11 q13 in human hepatoma cell line. Cancer Res 1991, 51:1460-1464
60. Yeh SH, Chen PJ, Lai MY, Chen DS: Allelic loss on chromosomes 4q and 16q in hepatocellular carcinoma. Gasteroenterology 1996, 110: 184-192
61. Zhang W, Hirohashi S, Tsuda H, Shimosato Y, Yokota J, Terada M, Sugimura T: Frequent loss of heterozygosity of chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn J Cancer Res 1990, 81: 108-111